Proud contributor to public health
Navamedic is a nordic pharma company and a reliable supplier of high-quality products.
12.09.2024
Navamedic announces an exclusive agreement with Alex Therapeutics for the development of a Companion App to aid in the treatment of Parkinson’s Disease
09.09.2024
Navamedic ASA – Mandatory notification of trade by primary insider
09.09.2024
NAVAMEDIC ASA: RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS
-
Employees
45
-
Revenue 2023 (MNOK)
512
-
EBITDA 2023 (MNOK)
51.6
-
Number of products
84
-
Countries where products are sold
13
-
Established in
2002
Financial Results
Take part of up-to-date financial results in our quarterly webcasts and reports.
View results
New treatment for erectile dysfunction
In February Navamedic launched Eroxon which is a clinically proven gel that helps men get an erection within 10 minutes.
Learn more